Nifty falls 0.61% as crude, banks and index-heavy stocks weigh

Indian equities closed lower as traders attributed the session's risk aversion to elevated crude prices and renewed tensions involving the United States and Iran. The pressure was concentrated in large index constituents, leaving the benchmark indices lower despite gains in selected defensive and defence-linked shares.

The reported market move reflected a combination of external risk and domestic stock-specific selling. The rupee weakened intraday as higher oil prices increased importer demand for dollars, while the oil and energy complex, banks and technology-linked shares faced pressure. The defence complex moved in the opposite direction after the Defence Acquisition Council cleared military acquisition proposals estimated at Rs 1.1 lakh crore.

ICICI Bank and Axis Bank were among the principal banking drags, while Reliance Industries, Maruti Suzuki, Bharti Airtel and Larsen & Toubro also came under pressure in intraday updates. The available reports did not provide a complete end-of-day attribution by stock, so the precise contribution of each constituent to the recorded index move is not available.

Bharat Electronics was the leading reported Nifty gainer as defence stocks drew support from the acquisition approvals. GE Vernova T&D India also advanced after emerging as the lowest bidder for a 6,000 MW, ±800 kV HVDC terminal-station project for renewable-power evacuation. These were stock-specific offsets rather than evidence of a broad recovery in risk appetite.

Pharma, healthcare and consumer-facing shares held up better. Reports linked the relative resilience of these groups to selective buying and defensive positioning, while the weakness in banks, oil and energy reflected the market's concern over funding conditions, imported inflation and the geopolitical risk premium.

The Defence Acquisition Council approved military procurement proposals for the three services, including radars, advanced light helicopters and mechanical mine layers, with an estimated value of Rs 1.1 lakh crore. The immediate market response was strongest in defence-linked shares, including Bharat Electronics.

The available material does not identify a fresh RBI, SEBI or finance ministry policy announcement on September 8. It also does not provide a new CPI, IIP, GST, trade or PMI release for the session. The market therefore traded primarily on oil, currency and geopolitical signals rather than a newly reported domestic macro print.

Asian markets were mixed to weaker as renewed geopolitical tensions pushed oil higher and strengthened the yen. Japanese shares declined as the currency weighed on exporters, while South Korean shares reversed an earlier rise. European equities were also softer in available reports, with higher oil prices reviving inflation and supply concerns.

The U.S. 10-year Treasury yield was reported near 4.79%, while traders continued to assess the possibility of a Federal Reserve rate increase at its September meeting. For India, the combination of higher global yields, a firmer dollar environment and costlier crude can keep pressure on foreign flows and rate-sensitive sectors, although the day's final FII and DII cash-market figures were not available in the material.

Corporate news was mixed. Shiprocket's first-quarter consolidated loss narrowed year-on-year as revenue increased, while Behari Lal Engineering reported higher first-quarter profit and revenue. SBI Life reported a 2.8% increase in new business premium, with year-to-date premium up 12.73%. The material did not include consensus estimates, so the results cannot be classified as beats or misses against market expectations.

Order and project announcements included TCS winning a Rs 122.6 crore contract for the next phase of Odisha's State Workflow Automation System, Neuland Laboratories approving Rs 126 crore of land-related capital expenditure, and Torrent Green Energy commissioning 322 MWp of decentralised solar projects in Maharashtra.

Mankind Pharma said shareholders had approved the voluntary liquidation of subsidiary Bharat Serums & Vaccines. Novartis India entered an exclusive promotion and distribution agreement for two Novartis Healthcare retina products. Vodafone Idea remained under pressure after HSBC cited risks around spectrum-payment obligations and operating cash flow. The available material contains no management-change announcement for the session.